GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » Research & Development

BioHarvest Sciences (XCNQ:BHSC) Research & Development : C$4.02 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is BioHarvest Sciences Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. BioHarvest Sciences's Research & Development for the three months ended in Mar. 2024 was C$1.40 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was C$4.02 Mil.

BioHarvest Sciences Research & Development Historical Data

The historical data trend for BioHarvest Sciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences Research & Development Chart

BioHarvest Sciences Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.47 1.62 5.29 3.14 4.52

BioHarvest Sciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.84 1.21 1.41 1.40

BioHarvest Sciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$4.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioHarvest Sciences  (XCNQ:BHSC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BioHarvest Sciences Research & Development Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

BioHarvest Sciences (XCNQ:BHSC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » Research & Development
Comparable Companies
TSXV:FRSH XCNQ:BOIL TSX:SWP TSX:BABY XCNQ:MOOO XCNQ:HBFG XCNQ:BITE TSX:BU NEOE:NGRB XCNQ:GFCO XSWX:NESN KHC GIS XPAR:BN SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF
Traded in Other Exchanges
CNVCF:USA 8MV:Germany
Address
1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6
Website
https://www.bioharvest.com
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

BioHarvest Sciences (XCNQ:BHSC) Headlines

No Headlines